BioNTech SE (BNTX)
Healthcare · Biological Products, (No Diagnostic Substances)
BioNTech SE (BNTX) stock research on InvestAtlant: institutional ownership from 13F filings, insider Form 4 activity, and SEC context.
Top institutional holders (2026-Q2)
| Institution | Shares | Value | % Outstanding |
|---|---|---|---|
| FMR LLC | 7,571,805 | $704.56M | — |
| PRIMECAP MANAGEMENT CO/CA/ | 3,772,031 | $350.99M | — |
| DODGE & COX | 3,677,591 | $342.20M | — |
| FLOSSBACH VON STORCH SE | 2,226,138 | $207.14M | — |
| T. Rowe Price Investment Management, Inc. | 2,065,456 | 92.2K | — |
| BlackRock, Inc. | 1,854,966 | 72.60M | — |
| Temasek Holdings (Private) Ltd | 1,506,027 | 40.14M | — |
| BNP PARIBAS FINANCIAL MARKETS | 1,319,517 | 22.78M | — |
Recent insider transactions
| Date | Insider | Title | Type | Value |
|---|---|---|---|---|
| 2026-09-22 | Sahin Ugur | Chief Executive Officer, 10% Owner | Sale | $4.63M |
| 2026-09-21 | Sahin Ugur | Chief Executive Officer, 10% Owner | Sale | $3.23M |
| 2026-09-18 | Sahin Ugur | Chief Executive Officer, 10% Owner | Sale | $2.89M |
| 2026-09-17 | Sahin Ugur | Chief Executive Officer, 10% Owner | Sale | $3.35M |
| 2026-09-16 | Sahin Ugur | Chief Executive Officer, 10% Owner | Sale | .44M |
| 2026-09-15 | Sahin Ugur | Chief Executive Officer, 10% Owner | Sale | $3.28M |
| 2026-09-14 | Sahin Ugur | Chief Executive Officer, 10% Owner | Sale | $4.08M |
| 2026-09-11 | Sahin Ugur | Chief Executive Officer, 10% Owner | Sale | $4.36M |